Researchers at the MTN include international investigators and community and industry partners who work together to evaluate promising microbicide products.
Studies at the Microbicide Trials Network are designed specifically to support the potential licensure and regulatory approval of HIV prevention products for populations most vulnerable to HIV.
The Microbicide Trials Network is a U.S. National Institutes of Health-funded worldwide collaborative clinical trials network focused on preventing the sexual transmission of HIV.
More than 25 clinical research sites on four continents have partnered with the Microbicide Trials Network in the conduct of its clinical trials.
The MTN partners with key civil society groups and other stakeholders to solicit their views on proposed studies and to discuss issues related to study implementation.
Spotlight on MTN-041
A cisgender woman who is eight months pregnant was the first participant enrolled into MTN-042 (DELIVER) which launched mid-February.
MTN-045 has launched.
MTN is pleased to announce the launch of MTN-039.
Presentations from our MTN 2020 Annual Meeting are posted.
The MTN held its final in-country stakeholder meeting for MTN-042 and MTN-043 in Harare, Zimbabwe, January 28-29, 2020.
Presentations and photos from our MTN 2019 Regional Meeting have been posted along with a music video about REACH.
Researchers launch DELIVER study to assess safety of PrEP and dapivirine vaginal ring in pregnant women
Results of open-label study of a vaginal ring for HIV prevention suggest women are interested in and willing to use it
Microbicide Trials Network